Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation

Published:2018-02-26 Issue:8 Volume:110 Page:914-917
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Cedrés Susana¹²,Felip Enriqueta¹²³,Cruz Cristina⁴²,Martinez de Castro Ana¹²,Pardo Nuria¹²³,Navarro Alejandro¹²³,Martinez-Marti Alex¹²³,Remon Jordin¹²,Zeron-Medina Jorge²,Balmaña Judith¹²³,Llop-Guevara Alba⁴,Miquel Josep M⁵,Sansano Irene⁶,Nuciforo Paolo⁷,Mancuso Francesco⁸,Serra Violeta⁴,Vivancos Ana⁸

Affiliation:

1. Thoracic Tumors Group, Vall d’hebron Institute of Oncology, Barcelona, Spain

2. Oncology Department, Vall d’hebron University Hsopital

3. Universidad Autonoma de Barcelona, Barcelona, Spain

4. Experimental Therapeutic Group, Barcelona, Spain

5. Vall d’hebron Institute of Oncology Barcelona, Spain

6. Pathology Department, Barcelona, Spain

7. Molecular Oncology Group, Barcelona, Spain

8. Cancer Genomic Group, Barcelona, Spain

Funder

Spanish Cancer Association

Scientific Foundation

Spanish Ministries of Health

Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional

Instituto de Salud Carlos III

Catalan Agency AGAUR

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/110/8/914/25452266/djy012.pdf

Reference22 articles.

1. Hereditary breast and ovarian cancer: New genes in confined pathways;Nielsen;Nat Rev Cancer.,2016

2. An update on PARP inhibitors-moving to the adjuvant setting;Sonnenblick;Nat Rev Clin Oncol.,2015

3. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases;Pal;Cancer.,2005

4. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada;McLaughlin;J Natl Cancer Inst.,2006

5. Germline BRCA mutations in a large clinic-based cohort of patients with pancreatic adenocarcinoma;Holter;J Clin Oncol.,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HSP90: A promising target for NSCLC treatments;European Journal of Pharmacology;2024-02

2. Host cell stress response as a predictor of COVID-19 infectivity and disease progression;Frontiers in Molecular Biosciences;2022-08-11

3. Identification of Germline Mutations in East-Asian Young Never-Smokers with Lung Adenocarcinoma by Whole-Exome Sequencing;Phenomics;2022-06-11

4. A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis;EMBO Molecular Medicine;2022-02-17

5. Potential predictive value of plasma heat shock protein 90α in lung cancer;Journal of International Medical Research;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3